{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PVI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVI\",,,,,undefined,":{"symbol":"PVI","market":"US","secType":"STK","nameCN":"Invesco Floating Rate Municipal Income ETF","latestPrice":24.765,"timestamp":1771441604264,"preClose":24.7563,"halted":0,"volume":1022,"delay":0,"changeRate":0.00035142569770123326,"floatShares":1250000,"shares":1250000,"eps":0,"marketStatus":"Trading","change":0.0087,"latestTime":"02-18 14:21:08 EST","open":24.7934,"high":24.7934,"low":24.765,"amount":25323.291784,"amplitude":0.001147,"askPrice":24.8,"askSize":225,"bidPrice":24.75,"bidSize":325,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771448400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":24.7563,"sharesOutstanding":1250000,"nav":24.82357,"aum":31029462.5,"dividendRate":0.022338,"bidAskSpread":0.003426,"preHourTrading":{"tag":"盘前","latestPrice":24.77,"preClose":24.7563,"latestTime":"08:00 EST","volume":250,"amount":6192.5,"timestamp":1771419604072,"change":0.0137,"changeRate":0.000553,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":24.75,"preClose":24.7563,"latestTime":"16:10 EST","volume":5,"amount":123.7815,"timestamp":1771362604430,"change":-0.0063,"changeRate":-0.000254,"amplitude":0},"volumeRatio":0.291393},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVI\",,,,,undefined,":{"symbol":"PVI","floatShares":1250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.291393,"shares":1250000,"dividePrice":0.5532,"high":24.7934,"amplitude":0.001147,"preClose":24.7563,"low":24.765,"week52Low":24.56,"pbRate":"--","week52High":25.18,"institutionHeld":0,"latestPrice":24.765,"committee":0.181818,"eps":0,"divideRate":0.022338,"volume":1022,"delay":0,"ttmEps":0,"open":24.7934,"prevYearClose":24.92,"prevWeekClose":24.7985,"prevMonthClose":24.805,"prevQuarterClose":24.92,"fiveDayClose":24.77,"twentyDayClose":24.79,"sixtyDayClose":24.8697},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVI\",params:#limit:5,,,undefined,":[{"date":"2026-01-20","symbol":"PVI","amount":0.05735,"announcedDate":"2026-01-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-20","defaultRemindTime":1768919400000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-23","payableDate":"2026-01-20","currency":"USD","dateTimestamp":1768885200000,"payDate":"2026-01-23"},{"date":"2025-12-22","symbol":"PVI","amount":0.05233,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-11-24","symbol":"PVI","amount":0.04967,"announcedDate":"2025-11-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-24","defaultRemindTime":1763994600000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-24","currency":"USD","dateTimestamp":1763960400000,"payDate":"2025-11-28"},{"date":"2025-10-20","symbol":"PVI","amount":0.05508,"announcedDate":"2025-10-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-20","defaultRemindTime":1760967000000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-24","payableDate":"2025-10-20","currency":"USD","dateTimestamp":1760932800000,"payDate":"2025-10-24"},{"date":"2025-09-22","symbol":"PVI","amount":0.04398,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Floating Rate Municipal Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVI\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-15","recordDate":"2016-03-17","paymentDate":"2016-03-31","value":0.00005,"currency":"USD"},{"executeDate":"2016-04-15","recordDate":"2016-04-19","paymentDate":"2016-04-29","value":0.00148,"currency":"USD"},{"executeDate":"2016-05-13","recordDate":"2016-05-17","paymentDate":"2016-05-31","value":0.0004,"currency":"USD"},{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-06-30","value":0.00012,"currency":"USD"},{"executeDate":"2016-07-15","recordDate":"2016-07-19","paymentDate":"2016-07-29","value":0.00082,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609538908","title":"Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2609538908","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609538908?lang=en_us&edition=fundamental","pubTime":"2026-02-06 06:40","pubTimestamp":1770331200,"startTime":"0","endTime":"0","summary":"Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF-BY-THE-SEA, Calif., Feb. 6, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company advancing pulsed field ablation  solutions for complex cardiac arrhythmias, today announced the presentation of late breaking clinical trial data from the first-in-human Field PULSE study at the 31st Annual International AF Symposium 2026, held February 5–7 in Boston.The FieldForce Ablation System by Field Medical. A focal PFA system designed to support transmural lesion creation for complex cardiac arrhythmias.These findings extend Field Medical's body of clinical evidence of its high-voltage focal PFA approach beyond ventricular arrhythmias and into the development of therapy for atrial fibrillation . Together with previously reported six-month first-in-human ventricular tachycardia  data, the results support the emergence of a versatile ablation p","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2878123/Field_Medical_Ablation_System.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2878123/Field_Medical_Ablation_System.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/field-medical-presents-late-breaking-field-pulse-trial-data-at-af-symposium-2026-302680670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VT","BK4585","PVI"],"gpt_icon":0},{"id":"2591649326","title":"Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649326","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591649326?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:30","pubTimestamp":1765801800,"startTime":"0","endTime":"0","summary":"Data from FDA-advised study demonstrates Lumee Oxygen tissue monitoring is a safe and effective long-term method in PAD patients and will support potential FDA submission; strongly correlates with tra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/15/3205315/0/en/Profusa-U-S-Study-Met-Primary-End-Points-as-Presented-at-Late-Breaking-Clinical-Trials-at-Paris-Vascular-Insights-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVI","PCOM","BK4122"],"gpt_icon":0},{"id":"2585462209","title":"Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462209","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462209?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:15","pubTimestamp":1763990100,"startTime":"0","endTime":"0","summary":"Study evaluates Lumee Oxygen tissue monitoring platform with transcutaneous partial pressure of oxygen (tcpO) in peripheral artery disease patients BERKELEY, Calif, Nov.  24, 2025  (GLOBE NEWSWIRE) --","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193475/0/en/Profusa-to-Present-Late-Breaking-U-S-Based-Clinical-Trial-Update-at-Paris-Vascular-Insights-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVI"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}